Inclusion complexation of p-hydroxybenzoic acid esters with 2-hydroxypropyl-beta-cyclodextrins. On changes in solubility and antimicrobial activity. 1993

H Matsuda, and K Ito, and Y Sato, and D Yoshizawa, and M Tanaka, and A Taki, and H Sumiyoshi, and T Utsuki, and F Hirayama, and K Uekama
Shiseido Research Laboratories, Kanagawa, Japan.

To obtain a transparent and effective solution of p-hydroxybenzoic acid esters (parabens), the use of 2-hydroxypropyl-beta-cyclodextrins (2-HP-beta-CyDs) as solubilizers with different degrees of substitution (D.S.) was surveyed. 2-HP-beta-CyDs significantly increased the aqueous solubility of four kinds of parabens (methyl < ethyl < propyl < butyl esters), where the solubilizing ability decreased with an increase in the D.S. of the 2-hydroxypropyl group in beta-CyD. The antimicrobial activity of the parabens tended to decrease by complexation with 2-HP-beta-CyDs. However, the activity could be maintained by lengthening the alkyl chain of the parabens. 1H- and 13C-nuclear magnetic resonance and circular dichroism spectroscopic studies suggest that the hydrophobic alkyl moiety of butyl paraben is preferably included in the cavity, and the phenol group extrudes from the cavity. The present results suggest that a suitable combination of 2-HP-beta-CyDs and hydrophobic, longer alkyl parabens is useful for the preservation of liquid formulations.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010226 Parabens Methyl, propyl, butyl, and ethyl esters of p-hydroxybenzoic acid. They have been approved by the FDA as antimicrobial agents for foods and pharmaceuticals. (From Hawley's Condensed Chemical Dictionary, 11th ed, p872) 4-Hydroxybenzoic Acids,Paraben,para-Hydroxybenzoic Acids,4 Hydroxybenzoic Acids,para Hydroxybenzoic Acids
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D003505 Cyclodextrins A homologous group of cyclic GLUCANS consisting of alpha-1,4 bound glucose units obtained by the action of cyclodextrin glucanotransferase on starch or similar substrates. The enzyme is produced by certain species of Bacillus. Cyclodextrins form inclusion complexes with a wide variety of substances. Cycloamylose,Cyclodextrin,Cyclodextrin Derivatives,Cyclomaltooligosaccharides,Derivatives, Cyclodextrin
D000073738 2-Hydroxypropyl-beta-cyclodextrin Derivative of beta-cyclodextrin that is used as an excipient for steroid drugs and as a lipid chelator. 2 Hydroxypropyl-beta-cyclodextrin,HP-beta-CD,HPbetaCD,Hydroxypropyl Betadex,Hydroxypropyl-beta-cyclodextrin,beta-Hydroxypropylcyclodextrin,2 Hydroxypropyl beta cyclodextrin,Betadex, Hydroxypropyl,Hydroxypropyl beta cyclodextrin,beta Hydroxypropylcyclodextrin
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D047392 beta-Cyclodextrins Cyclic GLUCANS consisting of seven (7) glucopyranose units linked by 1,4-glycosidic bonds. beta Cyclodextrins

Related Publications

H Matsuda, and K Ito, and Y Sato, and D Yoshizawa, and M Tanaka, and A Taki, and H Sumiyoshi, and T Utsuki, and F Hirayama, and K Uekama
October 1980, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
H Matsuda, and K Ito, and Y Sato, and D Yoshizawa, and M Tanaka, and A Taki, and H Sumiyoshi, and T Utsuki, and F Hirayama, and K Uekama
July 1976, Journal of pharmaceutical sciences,
H Matsuda, and K Ito, and Y Sato, and D Yoshizawa, and M Tanaka, and A Taki, and H Sumiyoshi, and T Utsuki, and F Hirayama, and K Uekama
April 1999, Drug development and industrial pharmacy,
H Matsuda, and K Ito, and Y Sato, and D Yoshizawa, and M Tanaka, and A Taki, and H Sumiyoshi, and T Utsuki, and F Hirayama, and K Uekama
November 2000, Journal of pharmaceutical sciences,
H Matsuda, and K Ito, and Y Sato, and D Yoshizawa, and M Tanaka, and A Taki, and H Sumiyoshi, and T Utsuki, and F Hirayama, and K Uekama
December 1999, The Journal of pharmacy and pharmacology,
H Matsuda, and K Ito, and Y Sato, and D Yoshizawa, and M Tanaka, and A Taki, and H Sumiyoshi, and T Utsuki, and F Hirayama, and K Uekama
July 1976, Die Pharmazie,
H Matsuda, and K Ito, and Y Sato, and D Yoshizawa, and M Tanaka, and A Taki, and H Sumiyoshi, and T Utsuki, and F Hirayama, and K Uekama
May 2002, Journal of pharmaceutical and biomedical analysis,
H Matsuda, and K Ito, and Y Sato, and D Yoshizawa, and M Tanaka, and A Taki, and H Sumiyoshi, and T Utsuki, and F Hirayama, and K Uekama
September 2012, Food chemistry,
H Matsuda, and K Ito, and Y Sato, and D Yoshizawa, and M Tanaka, and A Taki, and H Sumiyoshi, and T Utsuki, and F Hirayama, and K Uekama
May 2003, Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering,
H Matsuda, and K Ito, and Y Sato, and D Yoshizawa, and M Tanaka, and A Taki, and H Sumiyoshi, and T Utsuki, and F Hirayama, and K Uekama
October 2003, Drug development and industrial pharmacy,
Copied contents to your clipboard!